|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, (accretion) and amortization | |||||
| Stock-based compensation expense | |||||
| Deferred income tax expense | |||||
| Provision for credit losses | |||||
| ESOP expense | |||||
| Net loss (gain) on sale and writedown of other real estate owned | |||||
| Net loss on sale of investment securities | |||||
| Net gain on sale of other real estate owned | |||||
| Loss on sale of premises and equipment | |||||
| Increase in cash surrender value of bank owned life insurance | |||||
| Write-down on other real estate | |||||
| Change in: | |||||
| Accrued interest receivable and other assets | |||||
| Accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investment securities held-to-maturity | |||||
| Purchases of investment securities available-for-sale | |||||
| Purchases of premises and equipment | |||||
| Proceeds from disposal of premises and equipment | |||||
| Proceeds from the sale of investment securities available-for-sale | |||||
| Proceeds from sale of investment securities available-for-sale | |||||
| Proceeds from sale of investment securities held-to-maturity | |||||
| Proceeds from paydowns of investment securities available-for-sale | |||||
| Proceeds from paydowns and calls of investment securities held-to-maturity | |||||
| Purchases of other investments | |||||
| Proceeds from sales of other investments | |||||
| Net change in loans | |||||
| Purchase of bank owned life insurance | |||||
| Proceeds from sales of other real estate owned | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Common stock repurchase | |||||
| Proceeds from FHLB advances | |||||
| Repayment of FHLB advances | |||||
| Proceeds from federal funds purchased | |||||
| Repayment of federal funds purchased | |||||
| Dividends paid to shareholders | |||||
| Exercise of stock options | |||||
| Proceeds from other borrowings | |||||
| Repayment of other borrowings | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for income taxes | |||||
| Federal | |||||
| State | |||||
| Cash paid for interest | |||||
| Change in unrealized loss on investment securities available-for-sale, net of tax | |||||
| Carrying amount of secuirities held-to-maturity transferred to available-for-sale | |||||
Loading...